Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.490
-0.100 (-6.29%)
At close: Nov 14, 2025, 4:00 PM EST
1.510
+0.020 (1.34%)
After-hours: Nov 14, 2025, 7:58 PM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $61.46 million as of November 14, 2025. Its market cap has decreased by -76.88% in one year.
Market Cap
61.46M
Enterprise Value
41.47M
1-Year Change
-76.88%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $61.46M, a decrease of -95.39%. That is a compound annual growth rate of -45.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 61.46M | -77.08% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |